CAI - NASDAQ

Caris Life Sciences, Inc.

CAI·NASDAQ

$15.48

-1.5%

HealthcareBiotechnology

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.38B

EPS-1.9000

P/E Ratio-8.15

Earnings Date06/03/2026

cai

Other Financing Activities

Last Annual Value

-18.55M

3-Year CAGR

-38%

5-Year CAGR

29%

10-Year CAGR

-2%

Adjust for Inflation

Caris Life Sciences, Inc. Competitors Analysis of Other Financing Activities

CAI · NASDAQ

Company	Other Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Caris Life Sciences, Inc. NASDAQ:CAI	-18.55M	N/A	N/A	N/A
Moderna, Inc. NASDAQ:MRNA	19.00M	N/A	N/A	110.7%
Atrium Therapeutics, Inc. NASDAQ:RNA	42.57M	171.5%	91.8%	N/A
Cytokinetics, Incorporated NASDAQ:CYTK	-2.47M	N/A	N/A	N/A
Corcept Therapeutics Incorporated NASDAQ:CORT	25.49M	N/A	N/A	12.7%
Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL	0.00	N/A	N/A	N/A
Jazz Pharmaceuticals plc NASDAQ:JAZZ	-75.22M	N/A	N/A	N/A
Halozyme Therapeutics, Inc. NASDAQ:HALO	0.00	N/A	N/A	N/A
Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM	5.38M	-40.5%	2.5%	N/A

Caris Life Sciences, Inc. Fair Value Envelope

CAI · NASDAQ

Our analysis suggests that CAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.48, this represents a potential HIDDEN relative to our calculated worth for Caris Life Sciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $15.48

Related Guides

Blog Categories

Continue your CAI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.